Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,805,427
-
Share change
-
+1,226,488
-
Total reported value
-
$244,542,225
-
Put/Call ratio
-
47%
-
Price per share
-
$6.83
-
Number of holders
-
76
-
Value change
-
+$7,001,576
-
Number of buys
-
33
-
Number of sells
-
35
Institutional Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q1 2022
As of 31 Mar 2022,
AVADEL PHARMACEUTICALS - COM (AVDL) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,805,427 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, COWEN AND COMPANY, LLC, Polar Capital Holdings Plc, BRANDES INVESTMENT PARTNERS, LP, Vivo Capital, LLC, GENDELL JEFFREY L, WEALTH EFFECTS LLC, Woodline Partners LP, Avoro Capital Advisors LLC, and JANUS HENDERSON GROUP PLC.
This page lists
76
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.